University of Miami Miller School of Medicine — Miami, Florida

Public research footprint of University of Miami Miller School of Medicine, compiled from the ClinicalTrials.gov public registry.

739

Registered studies

280

Active

113

Recruiting now

346

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Locally Recurrent Head and Neck Squamous Cell Carcinoma

Recently updated registry entries

NCT03258554 — Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally… (Completed)
NCT05987241 — Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of… (Recruiting)
NCT05554328 — Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Miami Miller School of Medicine?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.